CD4
Journal
Cell death & disease
ISSN: 2041-4889
Titre abrégé: Cell Death Dis
Pays: England
ID NLM: 101524092
Informations de publication
Date de publication:
06 05 2022
06 05 2022
Historique:
received:
22
01
2022
accepted:
22
04
2022
revised:
21
04
2022
entrez:
6
5
2022
pubmed:
7
5
2022
medline:
11
5
2022
Statut:
epublish
Résumé
As a widely studied adoptive treatment method, CIK (cytokine-induced killer cells) treatment has shown clinical benefits in many clinical trials on non-small cell lung cancer. As a heterogeneous cell population, however, CIK cells have a strong instability and individual differences in their efficacies, which are collaboratively regulated by the tumor microenvironment and CIK subpopulations. Among them, CD4
Identifiants
pubmed: 35523765
doi: 10.1038/s41419-022-04882-x
pii: 10.1038/s41419-022-04882-x
pmc: PMC9076680
doi:
Types de publication
Clinical Trial, Phase II
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
441Informations de copyright
© 2022. The Author(s).
Références
Immunity. 2017 Nov 21;47(5):848-861.e5
pubmed: 29126798
Immunotherapy. 2011 Oct;3(10):1223-33
pubmed: 21995573
Int Immunopharmacol. 2015 Apr;25(2):450-6
pubmed: 25698555
Cell Res. 2017 Jan;27(1):109-118
pubmed: 27995907
Immunity. 2019 Dec 17;51(6):1028-1042.e4
pubmed: 31810883
Biomed Pharmacother. 2019 Jan;109:1728-1739
pubmed: 30551427
J Immunother. 2013 Oct;36(8):451-8
pubmed: 23994890
Cell Metab. 2020 Jan 7;31(1):148-161.e5
pubmed: 31761565
Cytokine Growth Factor Rev. 2017 Aug;36:99-105
pubmed: 28629761
Immunity. 2004 Apr;20(4):477-94
pubmed: 15084276
J Clin Invest. 2020 Jul 1;130(7):3560-3575
pubmed: 32229721
J Exp Med. 2020 Jan 6;217(1):
pubmed: 31727783
Front Immunol. 2021 Oct 05;12:761920
pubmed: 34675939
Int J Hematol. 2014 Aug;100(2):165-70
pubmed: 24929848
Signal Transduct Target Ther. 2020 Oct 19;5(1):244
pubmed: 33077722
Cancer Res. 2012 Jul 15;72(14):3570-81
pubmed: 22581824
Nat Immunol. 2019 Jul;20(7):879-889
pubmed: 31182807
Cancer Cell. 2018 Jun 11;33(6):1048-1060.e7
pubmed: 29894691
J Exp Med. 2015 Mar 9;212(3):333-49
pubmed: 25732306
J Exp Med. 2013 Jul 1;210(7):1463-79
pubmed: 23776078
Oncol Lett. 2021 Aug;22(2):613
pubmed: 34257721
Nat Rev Immunol. 2011 Feb;11(2):109-17
pubmed: 21233853
Gastroenterology. 2015 Jun;148(7):1383-91.e6
pubmed: 25747273
Cytotherapy. 2014 Jun;16(6):835-44
pubmed: 24582456
Cancer Cell. 2019 Jun 10;35(6):885-900.e10
pubmed: 31185212
Proc Natl Acad Sci U S A. 2010 Aug 17;107(33):14733-8
pubmed: 20679213
Hepatology. 2020 Oct;72(4):1310-1326
pubmed: 33090557
Front Immunol. 2016 Jun 20;7:241
pubmed: 27379101
Nat Rev Immunol. 2016 Feb;16(2):102-11
pubmed: 26781939
Nature. 2015 Jun 18;522(7556):345-348
pubmed: 25822788
Nat Rev Immunol. 2020 Mar;20(3):173-185
pubmed: 31676858
Cell Res. 2020 Aug;30(8):660-669
pubmed: 32467592
J Clin Med. 2019 Jun 12;8(6):
pubmed: 31212870
J Clin Immunol. 2007 May;27(3):317-26
pubmed: 17468835
Clin Cancer Res. 2012 Mar 15;18(6):1751-9
pubmed: 22275504
Nat Commun. 2017 Jun 06;8:15776
pubmed: 28585539
Nat Rev Immunol. 2018 Oct;18(10):635-647
pubmed: 30057419
J Cancer Res Clin Oncol. 2017 May;143(5):861-871
pubmed: 28108815